Indraprastha Medical Corporation Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 14.37% vs 6.03% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is 24.96% vs 11.45% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 18.70% vs 10.34% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -7.59% vs 81.61% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Indrapr.Medical With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

371.61

267.12

104.49

39.12%

Other Operating Income

0.00

Total Operating income

371.61

267.12

104.49

39.12%

Raw Material Cost

63.75

0.00

63.75

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

74.89

42.31

32.58

77.00%

Power Cost

0.00

Manufacturing Expenses

95.46

163.42

-67.96

-41.59%

Selling and Distribution Expenses

0.00

Other Expenses

75.56

17.59

57.97

329.56%

Total Expenditure (Excl Depreciation)

309.66

223.32

86.34

38.66%

Operating Profit (PBDIT) excl Other Income

61.95

43.80

18.15

41.44%

Other Income

7.15

7.49

-0.34

-4.54%

Operating Profit (PBDIT)

69.10

51.29

17.81

34.72%

Interest

1.46

6.59

-5.13

-77.85%

Exceptional Items

0.00

-3.07

3.07

100.00%

Gross Profit (PBDT)

67.64

41.63

26.01

62.48%

Depreciation

11.25

12.05

-0.80

-6.64%

Profit Before Tax

56.39

29.57

26.82

90.70%

Tax

15.39

7.06

8.33

117.99%

Provisions and contingencies

0.00

Profit After Tax

41.00

22.51

18.49

82.14%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

41.00

22.51

18.49

82.14%

Equity Capital

91.67

15.83

75.84

479.09%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

4.47

1.42

3.05

214.79%

Diluted Earnings per share

4.47

1.42

3.05

214.79%

Operating Profit Margin (Excl OI)

16.67%

16.40%

0.00

0.27%

Gross Profit Margin

18.20%

15.58%

0.00

2.62%

PAT Margin

11.03%

8.43%

0.00

2.60%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 371.61 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -2.47% vs 4.37% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 14.37% vs 6.03% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 41.00 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -17.10% vs -3.89% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 24.96% vs 11.45% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 61.95 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -13.13% vs -2.52% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 18.70% vs 10.34% in Dec 2024

Quarterly - Interest

Interest 1.46 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -3.31% vs -3.21% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -7.59% vs 81.61% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 16.67%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024